InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.02
(
0.04%
)
Bitcoin
68,553.57
(
0.06%
)

Replies to post #243965 on Biotech Values

Replies to #243965 on Biotech Values

DewDiligence

09/29/22 10:48 AM

#243971 RE: spongepaul #243965

OCUL—I am surprised by the drop in share price as I was very pleased with the results. 80% rescue free @six months is a success. Many thought 60% would be fantastic.

Investors appear to be skeptical that the data are enough of an improvement relative to monotherapy with high-dose Eylea (#msg-169896700). Moreover, it doesn’t help that regular-dose Eylea will soon have biosimilars.